UPDATE 1-Asterias’s stem cell therapy shows promise in study

Aug 31 (Reuters) – Asterias Biotherapeutics Inc said initial data from a small study showed that its lead stem cell therapy could improve mobility in patients paralyzed by a spinal cord injury. The company’s shares were up 25 percent at $5.26 in mid-day …

[Read the full article here]

Comments are closed.